Morning Light ipRGCNon-SCN Pathways Gate Slow-Wave Sleep via Dorsomedial Hypothalamus Thermoregulatory Circuits

Hypothesis

Morning sunlight entrains the suprachiasmatic nucleus (SCN) via melanopsin‑expressing ipRGCs, but a parallel ipRGC projection to the dorsomedial hypothalamus (DMH) drives acute drops in core temperature and promotes slow‑wave sleep (SWS) independent of circadian phase. We propose that the DMH‑projecting ipRGC subset releases glutamate and PACAP onto GABAergic neurons that inhibit the ventrolateral preoptic area (VLPO) disinhibiting sleep‑promoting circuits while simultaneously activating sympathetic brown‑adipose‑tissue (BAT) pathways to produce a rapid, light‑induced hypothermia that favors SWS accumulation.

Mechanistic Reasoning

1. Anatomical segregation – Recent ablation work shows ipRGCs outside the SCN are required for light‑induced hypothermia and sleepiness【https://elifesciences.org/articles/44358】. Retrograde tracing indicates a distinct subpopulation terminates in the DMH, a hub linking light input to thermoregulatory effector pathways【https://pmc.ncbi.nlm.nih.gov/articles/PMC6650245】.

2. Neurotransmitter profile – ipRGCs co‑release glutamate and pituitary adenylate cyclase‑activating peptide (PACAP). Both excite DMH neurons that project to the sympathetic premotor nuclei in the rostral raphe pallidus (rRPa), driving BAT thermogenesis and heat loss【https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12313382/】 (c‑Fos data).

3. Temperature‑sleep coupling – Acute core‑body‑temperature reductions of ~0.3 °C increase SWS propensity by shifting the sleep‑homeostatic process toward deeper stages【https://www.sleepgeni.us/post/how-light-shapes-our-circadian-rhythms-why-sunlight-and-artificial-light-matter-for-health-and-slee】. The DMH‑mediated hypothermia thus provides a permissive window for SWS without altering total sleep time.

4. Integration with circadian entrainment – SCN‑projecting ipRGCs maintain phase alignment, while the DMH pathway adds a temporally gated “sleep‑depth” boost that is strongest when light occurs within 1–2 h after waking, matching the empirical window for maximal sleep‑midpoint advance【https://pmc.ncbi.nlm.nih.gov/articles/PMC12502225】.

Testable Predictions

• Prediction 1: Chemogenetic inhibition of ipRGC→DMH terminals (using AAV‑DIO‑hM4Di injected into the eye of ipRGC‑Cre mice) will abolish the light‑induced drop in core temperature and the accompanying increase in SWS during the morning, without affecting SCN‑dependent phase shifts.
• Prediction 2: Optogenetic activation of the same pathway during the subjective day will produce a rapid hypothermia and increase SWS power in EEG, even when ambient temperature is held constant.
• Prediction 3: In humans, wearing short‑wavelength‑blocking glasses that attenuate melanopsin stimulation but preserve ipRGC activation (e.g., 480 nm‑filtered light) will blunt the morning‑light‑induced SWS enhancement, measurable via polysomnography, while melatonin suppression remains intact.
• Prediction 4: Pharmacological blockade of PACAP receptors in the DMH will reduce the hypothermic response to morning light and attenuate SWS gains, confirming the neurotransmitter mediator.

Potential Confounds and Controls

• Light intensity must be calibrated to >250 lux at the cornea to ensure ipRGC activation without rod/cone saturation.
• Core temperature should be measured via telemetry or ingestible pills to avoid masking effects of activity.
• EEG scoring must blinded to condition; SWS defined as stages N3/N4 (0.5–2 Hz delta power).
• Circadian phase assessed via melatonin onset to ensure observations are not secondary to phase shifts.

By delineating a non‑SCN ipRGC→DMH circuit that couples light‑driven thermoregulation to sleep depth, this hypothesis bridges the gap between circadian entrainment and the fine‑tuning of sleep architecture, offering concrete, falsifiable experiments for both animal models and human trials.